We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$5.51B
Cap. Flow %
1.92%
Top 10 Hldgs %
12.98%
Holding
8,864
New
807
Increased
4,306
Reduced
2,683
Closed
688

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.31%
2 Technology 9.89%
3 Financials 7.42%
4 Healthcare 6.84%
5 Consumer Discretionary 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KFFB icon
6926
Kentucky First Federal Bancorp
KFFB
$45.1M
$18K ﹤0.01%
2,269
+1,269
+127% +$9.58K
KOLD icon
6927
ProShares UltraShort Bloomberg Natural Gas
KOLD
$92.2M
$18K ﹤0.01%
47
+40
+571% +$12.6K
MBRX icon
6928
Moleculin Biotech
MBRX
$12.3M
$18K ﹤0.01%
9
+4
+80% +$9.37K
MRIN
6929
DELISTED
Marin Software
MRIN
$18K ﹤0.01%
2,062
+78
+4% +$859
NRXP icon
6930
NRX Pharmaceuticals
NRXP
$130M
$18K ﹤0.01%
173
+20
+13% +$2.11K
OPRA
6931
Opera Ltd
OPRA
$1.57B
$18K ﹤0.01%
1,940
+941
+94% +$9.23K
PLTM icon
6932
GraniteShares Platinum Shares
PLTM
$193M
$18K ﹤0.01%
1,899
+1,569
+475% +$14.2K
SIM icon
6933
Grupo SIMEC
SIM
$4.43B
$18K ﹤0.01%
1,769
-200
-10% -$1.89K
TAYD icon
6934
Taylor Devices
TAYD
$204M
$18K ﹤0.01%
1,711
-99
-5% -$1.04K
USAU icon
6935
US Gold Corp
USAU
$258M
$18K ﹤0.01%
2,287
+2,284
+76,133% +$18.7K
WLDR icon
6936
Simplify Affinity World Leaders Equity ETF
WLDR
$125M
$18K ﹤0.01%
748
– –
CHNA
6937
DELISTED
Loncar China BioPharma ETF
CHNA
$18K ﹤0.01%
+732
New +$17.4K
VYNT
6938
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$18K ﹤0.01%
608
-202
-25% -$4.83K
ASPU
6939
DELISTED
ASPEN GROUP, INC.
ASPU
$18K ﹤0.01%
2,213
+714
+48% +$4.66K
ISEM
6940
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Emerging Markets ETF
ISEM
$18K ﹤0.01%
656
+549
+513% +$13.9K
AMRB
6941
DELISTED
American River Bankshares
AMRB
$18K ﹤0.01%
1,227
+81
+7% +$1.18K
HCAP
6942
DELISTED
Harvest Capital Credit Corporation
HCAP
$18K ﹤0.01%
2,043
+1,942
+1,923% +$18.1K
EXPCU
6943
DELISTED
Experience Investment Corp. Unit
EXPCU
$18K ﹤0.01%
1,800
-5,000
-74% -$50.2K
LOACU
6944
DELISTED
Longevity Acquisition Corporation Units
LOACU
$18K ﹤0.01%
1,716
– –
ACAMU
6945
DELISTED
Acamar Partners Acquisition Corp Units
ACAMU
$18K ﹤0.01%
1,800
-400
-18% -$4.06K
TRNE.U
6946
DELISTED
Trine Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of
TRNE.U
$18K ﹤0.01%
1,747
– –
DTUS
6947
DELISTED
iPath US Treasury 2-year Bear ETN
DTUS
$18K ﹤0.01%
524
+118
+29% +$3.93K
ROYT
6948
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$18K ﹤0.01%
34,432
+24,706
+254% +$20.4K
GPAQU
6949
DELISTED
Gordon Pointe Acquisition Corp. Unit
GPAQU
$18K ﹤0.01%
1,654
+400
+32% +$4.32K
DTO
6950
DELISTED
DB Crude Oil Double Short Exchange Traded Notes due June 1, 2038
DTO
$18K ﹤0.01%
391
+104
+36% +$5.65K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 807 new, 4,306 increased, 2,683 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 50% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 807 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.